The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Emergency Guide to FDA Warning Letters & FDA 483 FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA Issues Warning Letters to Companies Selling Dietary Supplements that Claim to Treat Cardiovascular Disease FDA Is BPC 157 Banned? Oral vs. Injectable Forms Explained FTC and U.S. FDA Warning Letter re: Products Containing CBD October 22, 2019